BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kafrouni M, Allimant C, Fourcade M, Vauclin S, Guiu B, Mariano-Goulart D, Ben Bouallègue F. Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy. EJNMMI Res 2019;9:62. [PMID: 31332585 DOI: 10.1186/s13550-019-0533-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang C, Ngam PI, Phua VJX, Yu SWK, Apoorva G, Ng DCE, Huang HL. Radiochemical Feasibility of Mixing of 99mTc-MAA and 90Y-Microspheres with Omnipaque Contrast. Molecules 2022;27:7646. [DOI: 10.3390/molecules27217646] [Reference Citation Analysis]
2 Salem R, Padia SA, Lam M, Chiesa C, Haste P, Sangro B, Toskich B, Fowers K, Herman JM, Kappadath SC, Leung T, Sze DY, Kim E, Garin E. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05956-w] [Reference Citation Analysis]
3 Garin E, Guiu B, Edeline J, Rolland Y, Palard X. Trans-arterial Radioembolization Dosimetry in 2022. Cardiovasc Intervent Radiol 2022. [PMID: 35982334 DOI: 10.1007/s00270-022-03215-x] [Reference Citation Analysis]
4 Budzyńska A, Kubik A, Kacperski K, Szubstarska P, Kuć M, Piasecki P, Konior M, Gryziński M, Dziuk M, Iller E. PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: anthropomorphic phantom study.. [DOI: 10.1101/2022.07.07.22277361] [Reference Citation Analysis]
5 Santoro M, Della Gala G, Paolani G, Zagni F, Strolin S, Civollani S, Calderoni L, Cappelli A, Mosconi C, Lodi Rizzini E, Tabacchi E, Morganti AG, Fanti S, Golfieri R, Strigari L. A novel tool for motion-related dose inaccuracies reduction in 99mTc-MAA SPECT/CT images for SIRT planning. Phys Med 2022;98:98-112. [PMID: 35526374 DOI: 10.1016/j.ejmp.2022.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lam M, Garin E, Maccauro M, Kappadath SC, Sze DY, Turkmen C, Cantasdemir M, Haste P, Herrmann K, Alsuhaibani HS, Dreher M, Fowers KD, Salem R. A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study. Eur J Nucl Med Mol Imaging 2022. [PMID: 35394152 DOI: 10.1007/s00259-022-05774-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Guiu B, Garin E, Allimant C, Edeline J, Salem R. TARE in Hepatocellular Carcinoma: From the Right to the Left of BCLC. Cardiovasc Intervent Radiol 2022. [PMID: 35149884 DOI: 10.1007/s00270-022-03072-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Lawhn-heath C, Hope TA, Martinez J, Fung EK, Shin J, Seo Y, Flavell RR. Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose. The Lancet Oncology 2022;23:e75-87. [DOI: 10.1016/s1470-2045(21)00657-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
9 Miller C, Rousseau J, Ramogida CF, Celler A, Rahmim A, Uribe CF. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs. Theranostics 2022;12:232-59. [PMID: 34987643 DOI: 10.7150/thno.62851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Walrand S, Hesse M. SPECT/CT for Dosimetry. Clinical Applications of SPECT-CT 2022. [DOI: 10.1007/978-3-030-65850-2_3] [Reference Citation Analysis]
11 Pettinato C, Richetta E, Cremonesi M. Dosimetry with single photon emission tomography (SPECT). Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00173-3] [Reference Citation Analysis]
12 Pandit-Taskar N, Iravani A, Lee D, Jacene H, Pryma D, Hope T, Saboury B, Capala J, Wahl RL. Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice. J Nucl Med 2021;62:60S-72S. [PMID: 34857623 DOI: 10.2967/jnumed.121.262977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Subreville C, Pinaquy JB, Lapuyade B, Blanc JF, Bordenave L, Papadopoulos P, Debordeaux F. Key Role of Personalized Dosimetry in Dose Adjustment for Selective Internal Radiotherapy: Retrospective Study of Patients Treated With 90Y Resin Microspheres. Clin Nucl Med 2021;46:958-64. [PMID: 34507332 DOI: 10.1097/RLU.0000000000003892] [Reference Citation Analysis]
14 d'Abadie P, Walrand S, Goffette P, Amini N, Maanen AV, Lhommel R, Jamar F. Antireflux catheter improves tumor targeting in liver radioembolization with resin microspheres. Diagn Interv Radiol 2021;27:768-73. [PMID: 34792032 DOI: 10.5152/dir.2021.20785] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Roosen J, Arntz MJ, Janssen MJR, de Jong SF, Fütterer JJ, Overduin CG, Nijsen JFW. Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres. Cancers (Basel) 2021;13:5462. [PMID: 34771626 DOI: 10.3390/cancers13215462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Willowson KP, Eslick EM, Bailey DL. Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma. EJNMMI Phys 2021;8:65. [PMID: 34519900 DOI: 10.1186/s40658-021-00406-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 d'Abadie P, Walrand S, Hesse M, Amini N, Lhommel R, Sawadogo K, Jamar F. Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres. Phys Med 2021;89:250-7. [PMID: 34438353 DOI: 10.1016/j.ejmp.2021.07.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
18 Meine TC, Brunkhorst T, Werncke T, Schütze C, Vogel A, Kirstein MM, Dewald CLA, Becker LS, Maschke SK, Kretschmann N, Wacker FK, Hinrichs JB, Meyer BC. Comparison of the Uptake of Hepatocellular Carcinoma on Pre-Therapeutic MDCT, CACT, and SPECT/CT, and the Correlation with Post-Therapeutic PET/CT in Patients Undergoing Selective Internal Radiation Therapy. J Clin Med 2021;10:3837. [PMID: 34501284 DOI: 10.3390/jcm10173837] [Reference Citation Analysis]
19 Allimant C, Deshayes E, Kafrouni M, Santoro L, de Verbizier D, Fourcade M, Cassinotto C, Hermida M, Guillot C, Mariano-Goulart D, Guiu B. Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver. Diagnostics (Basel) 2021;11:931. [PMID: 34064296 DOI: 10.3390/diagnostics11060931] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
20 Filippi L, Pelle G, Di Costanzo GG, Tortora R, Saltarelli A, Bagni O. 18F-choline PET-aided repeated 90Y-radioembolization in a patient with large hepatocellular carcinoma and portal vein tumor thrombosis. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2021;40:181-3. [DOI: 10.1016/j.remnie.2020.04.007] [Reference Citation Analysis]
21 Klement'eva O, Vlasova O, Stepchenkov D, Luneva K, Ternovskaya K, Petriev V, Stepchenkova E, Kuznetsov A, Artamonov S, Murashin K, Shegai P, Ivanov S, Kaprin A. Results of Preclinical Safety Tests of Radiopharmaceutical with 90Y for Intra-arterial Radioembolization of Liver Cancer. Medical Radiology and radiation safety 2021;65:51-59. [DOI: 10.12737/1024-6177-2020-65-5-51-59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Thompson BC, Dezarn WA. Retrospective SPECT/CT dosimetry following transarterial radioembolization. J Appl Clin Med Phys 2021;22:143-50. [PMID: 33710776 DOI: 10.1002/acm2.13213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Nodari G, Popoff R, Riedinger JM, Lopez O, Pellegrinelli J, Dygai-Cochet I, Tabouret-Viaud C, Presles B, Chevallier O, Gehin S, Gallet M, Latournerie M, Manfredi S, Loffroy R, Vrigneaud JM, Cochet A. Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy. EJNMMI Res 2021;11:24. [PMID: 33687596 DOI: 10.1186/s13550-021-00766-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Filippi L, Pelle G, Di Costanzo GG, Tortora R, Saltarelli A, Bagni O. 18F-choline PET-aided repeated 90Y-radioembolization in a patient with large hepatocellular carcinoma and portal vein tumor thrombosis. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:181-3. [PMID: 33551342 DOI: 10.1016/j.remn.2020.03.018] [Reference Citation Analysis]
25 Alsultan AA, Braat AJAT, Smits MLJ, Barentsz MW, Bastiaannet R, Bruijnen RCG, de Keizer B, de Jong HWAM, Lam MGEH, Maccauro M, Chiesa C. Current Status and Future Direction of Hepatic Radioembolisation. Clin Oncol (R Coll Radiol) 2021;33:106-16. [PMID: 33358630 DOI: 10.1016/j.clon.2020.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, Vouche M, Flamen P, Reynaert N. Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer. EJNMMI Phys 2020;7:75. [PMID: 33315160 DOI: 10.1186/s40658-020-00345-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Cheng B, Sethi I, Davisson N, Brandon D, Barron B, Galt J, Bercu Z, Schuster DM, Kokabi N. Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer. Nucl Med Commun 2021;42:402-9. [PMID: 33306630 DOI: 10.1097/MNM.0000000000001345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Morán V, Prieto E, Sancho L, Rodríguez-Fraile M, Soria L, Zubiria A, Martí-Climent JM. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods? EJNMMI Phys 2020;7:72. [PMID: 33284389 DOI: 10.1186/s40658-020-00343-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
29 Auditore L, Amato E, Boughdad S, Meyer M, Testart N, Cicone F, Beigelman-Aubry C, Prior JO, Schaefer N, Gnesin S. Monte Carlo 90Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation. Phys Med Biol 2020;65:235014. [PMID: 33245055 DOI: 10.1088/1361-6560/abbc80] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Brosch J, Gosewisch A, Kaiser L, Seidensticker M, Ricke J, Zellmer J, Bartenstein P, Ziegler S, Ilhan H, Todica A, Böning G. 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates. Phys Med 2020;80:317-26. [PMID: 33248338 DOI: 10.1016/j.ejmp.2020.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Martin M, Hocquelet A, Debordeaux F, Bordenave L, Blanc JF, Papadopoulos P, Lapuyade B, Trillaud H, Pinaquy JB. Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres. Diagn Interv Imaging 2021;102:45-52. [PMID: 33032960 DOI: 10.1016/j.diii.2020.09.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Thomas MA, Mahvash A, Abdelsalam M, Kaseb AO, Kappadath SC. Planning dosimetry for 90 Y radioembolization with glass microspheres: Evaluating the fidelity of 99m Tc-MAA and partition model predictions. Med Phys 2020;47:5333-42. [PMID: 32790882 DOI: 10.1002/mp.14452] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
33 Hammami H, Lalys F, Rolland Y, Petit A, Haigron P. Catheter navigation support for liver radioembolization guidance: feasibility of structure-driven intensity-based registration. Int J Comput Assist Radiol Surg 2020;15:1881-94. [PMID: 32870445 DOI: 10.1007/s11548-020-02250-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Garin E, Palard X, Rolland Y. Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design. Cancers (Basel) 2020;12:E1557. [PMID: 32545572 DOI: 10.3390/cancers12061557] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 14.5] [Reference Citation Analysis]
35 Kennedy JA, Lugassi R, Gill R, Keidar Z. Digital Solid-State SPECT/CT Quantitation of Absolute 177Lu Radiotracer Concentration: In Vivo and In Vitro Validation. J Nucl Med 2020;61:1381-7. [PMID: 32111686 DOI: 10.2967/jnumed.119.239277] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]